Welcome to Extreme Investor Network, where we provide you with the latest insights and analysis on the world of investing. Today, we’re diving into Friday’s biggest calls on Wall Street, giving you a glimpse into the recommendations and upgrades that are shaping the market.
Raymond James has initiated Arm as outperform, highlighting the company’s strong positioning in the realm of AI. With a price target of $160, Arm Holdings is poised to benefit from the rapid growth of AI in both cloud and edge computing.
Jefferies has initiated Vistra as a buy, citing the electricity generation company as a best idea with various upside opportunities in the power sector. Vistra is well positioned to tap into these opportunities and drive growth.
Citi has upgraded SL Green to neutral from sell, noting a rebound in the New York office market for the real estate investment trust. SL Green has shown resilience in refinancing debt maturities and maintaining strong leasing demand.
CFRA has upgraded Kroger to buy from hold, highlighting improving sales momentum and margin expansion opportunities. The stock’s valuation is seen as undemanding compared to its retail peers.
Macquarie has upgraded Rio Tinto to outperform from neutral based on valuation, despite EPS cuts in the forecast. The metals and mining company is poised for growth and value creation.
In contrast, Deutsche Bank has downgraded AstraZeneca to sell from hold, expressing concerns about the biopharma’s pipeline and innovation trajectory. The reality of certain assets not meeting expectations has prompted this downgrade.
Citi has also downgraded Capri Holdings to neutral from buy, citing a more balanced risk/reward profile for the owner of brands like Michael Kors. The FTC challenge of the TPR/CPRI deal is seen as lacking merit.
On the tech front, Barclays has downgraded Garmin to underweight from equal weight due to negative catalysts impacting the wearables tech company. Valuation concerns and gross margin headwinds have led to this downgrade.
Moving into the energy sector, BMO has initiated GE Vernova as outperform, recognizing the company as a global market leader in the power sector. GE Vernova’s position in the energy transition market is a key driver for this bullish call.
Pivotal has initiated TKO Holdings as a buy, highlighting the company’s unique position as a durable sports and entertainment asset. With a target price of $170 by the end of 2025, TKO Holdings is set for growth.
In the world of energy, Morgan Stanley has named EQT a top pick, signaling its strong position in the sector and potential for re-rating. Catalysts like asset sales and synergy realization are expected to drive returns for shareholders.
UBS has reiterated Oracle as a buy, raising its price target on the stock based on positive feedback and growth prospects from industry events and checks. PNC has also been reiterated as a buy, with strong potential for NII growth and strategic positioning.
JPMorgan is standing by Netflix as overweight, noting the streaming giant’s impact on the disruption of linear TV and strong subscriber growth. NFLX continues to be a key player driving revenue and profit growth.
Citi has resumed coverage of Eli Lilly as buy, citing upside potential across its broad portfolio and strong positioning in the market. Canaccord has reiterated Tesla as buy, despite share price pressure, citing the company’s market share and performance in the Chinese BEV sector.
On the biotech front, JPMorgan has downgraded Moderna to underweight from equal weight, expressing concerns about revenue targets. The reset to Moderna’s long-term guidance has prompted a reassessment of top and bottom-line estimates.
Finally, Wells Fargo has reiterated Nvidia as overweight, highlighting the company’s strong position in AI and lack of clear threats in the market. Nvidia’s dominance in the AI training sector is expected to drive growth and value creation.
Stay tuned for more updates and analysis on Extreme Investor Network, where we bring you the latest insights and recommendations to help you navigate the world of investing with confidence.